Risk management action milestones for Batch 12 chemical substances

The chemical substance listed below is from Batch 12 of the Challenge, and this substance has met the criteria of section 64 (a) of the Canadian Environmental Protection Act, 1999 (CEPA 1999). The table below compiles the proposed risk management actions for health and environment and provides the current status and any updated information for these proposed actions. For the complete wording of these proposed actions, please refer to the risk management approach document listed in the Summary of Batch 12 substances and publications.

Batch 12
CAS No. 53-19-0
Common Name: mitotane
Authority Risk management actions Most recent milestone
CEPA 1999 Significant New Activity (SNAc) provision. Application of the SNAc provisions is being considered.
CEPA 1999 Virtual elimination (VE) Will not be implemented because of mitotane’s use as a therapeutic cancer drug. For information on mitotane and therapeutic drugs, please visit the Drug and health products web page.
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: